Thyroid hormone and its mimetics, which have shown promising results in human NAFLD, are known to activate hepatic autophagy via the ROS-AMPK-ULK1 pathway in human hepatic cells to limit oxidative stress [73,74] (Figure 1). Here, TG is linked to metabolic dysfunction-associated steatotic liver disease.